Opinions

Pages

Displaying 1 - 10 of 2335
In elaborazione (updated on 17/01/2021)
Riferimento: 
NAT/801-EESC-2020
Sessione plenaria: 
557 -
Jan 27, 2021 Jan 28, 2021

The Atlantic maritime strategy was adopted in 2011 to support the sustainable development of blue economy in the EU Member States bordering the Atlantic. In 2013, the European Commission put forward an Atlantic action plan to implement the strategy.

To give a new boost to a sustainable maritime economy that can create jobs, the European Commission proposes to update the priorities for regional cooperation, following stakeholders’ consultation. The update is also a fresh contribution to Europe’s recovery from the unprecedented socio-economic crisis triggered by the current COVID-19 pandemic.

Nota d'informazione: Revised action plan for the Atlantic strategy

In elaborazione (updated on 17/01/2021)
Riferimento: 
NAT/808-EESC-2020
Sessione plenaria: 
557 -
Jan 27, 2021 Jan 28, 2021

Nota d'informazione: Application of the Aarhus Convention - Access to Justice in Environmental Matters

In elaborazione (updated on 15/01/2021)
Riferimento: 
INT/932-EESC-2021-00048-00-00-AC-TRA
Sessione plenaria: 
560 -
Apr 27, 2021 Apr 28, 2021

This Communication proposes a toolbox for the digitalisation of justice, in order to tackle the challenges in this field and move the justice sector forward in the digital area. The Commission is proposing an approach that takes into account the Member States’ differing national circumstances, national competences, and fully respects the principles of subsidiarity and proportionality.

 

Nota d'informazione: Digitalisation of justice

In elaborazione (updated on 15/01/2021)
Riferimento: 
INT/926-EESC-2020
Sessione plenaria: 
560 -
Apr 27, 2021 Apr 28, 2021

The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.

Nota d'informazione: Pharmaceutical strategy

In elaborazione (updated on 15/01/2021)
Riferimento: 
INT/923-EESC-2020
Sessione plenaria: 
557 -
Jan 27, 2021 Jan 28, 2021

The proposed Regulation aims at adapting the Joint Undertaking in order to use the funding from the new MFF programmes for 2021-2027.

Parere della sezione del CESE: Joint undertaking / High-performance computing

Pages